NCT05372120 2023-01-04
A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2 Unknown
Clinical Trials
3 trialsNCT04886271 2022-04-28
Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors
Waterstone Hanxbio Pty Ltd
Phase 2 Unknown
NCT03704246 2021-03-04
Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors
Taizhou Hanzhong biomedical co. LTD
Phase 2 Unknown